GGrantIndex
← Leaderboards

Harold M. McClure

Emory University

$3,517,681
Attributed
$3,517,681
Total exposure
11
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $618.1K · FY200506
$1M$750K$500K$250K$0
'05
'06

Funding mix

By agency

NIH$3,517,681 · 11

By mechanism

P01$1,942,736 · 5
R01$1,200,000 · 1
P51$374,945 · 5

Top collaborators

No co-investigators on record.

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Macaca Mulatta

Research focus

Macaca MulattaAnimal ColonyHistologyVaccine DevelopmentBiomedical FacilityAids VaccinesPolymerase Chain ReactionFlow CytometryProtease InhibitorDisease /Disorder ModelDrug Adverse EffectDrug InteractionsEnzyme ActivityFree Radical ScavengersHiv InfectionsArginineAscorbateLipid PeroxidesNitric OxideNitric Oxide SynthaseNonhuman Therapy EvaluationPeroxynitritesVascular EndotheliumSimian Immunodeficiency Virus

Grant awards (24)

Supplement - Primate Studies$618,149
P01 · FY2006 · AI · contact PI
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$54,508
P51 · FY2005 · RR
EFFECT OF HIV PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNC$240,000
R01 · FY2004 · HL
EFFECT OF HIS PROTEASE INHIBITOR ON ENDOTHELIAL FUNCTION$91,436
P51 · FY2004 · RR
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$60,875
P51 · FY2004 · RR
EFFECT OF HIV PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNC$240,000
R01 · FY2003 · HL
EFFECT OF HIS PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNCTION NHP CORE$83,876
P51 · FY2003 · RR
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$53,077
P51 · FY2003 · RR
ISOLATION OF A SUSPECTED ALPHA HERPES VIRUS-LIKE AGENT FROM SOOTY MANGABEYS$31,173
P51 · FY2003 · RR
EFFECT OF HIV PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNC$240,000
R01 · FY2002 · HL
Core--Primate facility$171,469
P01 · FY2002 · AI
CORE--PRECLINICAL TRIALS AND PATHOLOGY$159,181
P01 · FY2002 · AI
CORE--ANIMAL TRIALS FACILITY$0
P01 · FY2002 · AI
Core--Macaque studies$0
P01 · FY2002 · AI
EFFECT OF HIV PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNC$240,000
R01 · FY2001 · HL
Core--Primate facility$171,469
P01 · FY2001 · AI
CORE--PRECLINICAL TRIALS AND PATHOLOGY$159,181
P01 · FY2001 · AI
CORE--ANIMAL TRIALS FACILITY$0
P01 · FY2001 · AI
CORE--ANIMAL TRIALS FACILITY$0
P01 · FY2001 · AI
Core--Macaque studies$0
P01 · FY2001 · AI
CORE--PRECLINICAL TRIALS AND PATHOLOGY$256,006
P01 · FY2000 · AI
EFFECT OF HIV PROTEASE INHIBITORS ON ENDOTHELIAL DYSFUNC$240,000
R01 · FY2000 · HL
CORE--ANIMAL TRIALS FACILITY$235,812
P01 · FY2000 · AI
Core--Primate facility$171,469
P01 · FY2000 · AI